Log in

Start Your Membership Now

January 18, 2011 A January 18, 2011 U.S. Food and Drug Administration (FDA) advisory committee meeting discussed recommending approving the use of brain scans and the imaging compound, Amyvid, to help rule out Alzheimer’s disease as a cause of cognitive decline. U.S. Food and Drug Administration (FDA). Download the Report . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Market Intelligence Resource | January 18, 2011

FDA Advisory Committee Briefing Document: New Drug Application 202-008 Amyvid™ (Florbetapir F 18 Injection), sponsored by Avid Radiopharmaceuticals

January 18, 2011 A January 18, 2011 U.S. Food and Drug Administration (FDA) advisory committee meeting discussed recommending approving the use of brain scans and the imaging compound, Amyvid, to help rule out Alzheimer’s disease as a cause of cognitive decline. U.S. Food and Drug Administration (FDA). Download the Report . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.